𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between the induction of leukemia cell differentiation and the enhancement of reporter gene expression in 3T3 Swiss cells

✍ Scribed by Kimiko Ishiguro; Alan C. Sartorelli


Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
631 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Differential activity of the RVF enhance
✍ Duen-Hwa Yan; Mien-Chie Hung πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 628 KB

## Abstract The rat __neu__ oncogene encodes a growth factor receptorβ€”like glycoprotein, termed p185, that shares structural similarity with epidermal growth factor receptor (EGFR), particularly in the tyrosine‐kinase domain. The Swiss Webster 3T3 murine embryo fibroblast (SW3T3) variant NR‐6, in c

Differential effects of n-6 and n-3 poly
✍ Ulrich Danesch; Peter C. Weber; Alois Sellmayer πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 869 KB

Dietary n-3 polyunsaturated fatty acids (PUFAs) have been found to reduce accelerated cell growth. To study the underlying molecular mechanisms, we evaluated the effects of the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared with the n-6 PUFA arachidonic acid (AA) on ce

Epidermal growth factor and bombesin dif
✍ Arjo J. Bierman; Leo Koenderman; Anton J. Tool; W. De Laat Siegfried πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 910 KB

## Abstract Swiss 3T3 cells express receptors for both the polypeptide epidermal growth factor (EGF) and the tetradecapeptide bombesin and respond mitogenically to these substances. These cells thus provide a system to analyze potential signal transduction pathways involved in mitogenic stimulation

Differential gene-expression profiling i
✍ Masanori Daibata; Yoshinobu Matsuo; Hisanori Machida; Takahiro Taguchi; Yuji Oht πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 210 KB

## Abstract As a rule, T cell large granular lymphocyte (T‐LGL) leukemia runs a chronic clinical course without need for therapy. Some cases, however, progress to an aggressive disease after the indolent clinical stage. The transformation mechanism into a high‐grade malignancy has not been well stu